nodes	percent_of_prediction	percent_of_DWPC	metapath
Guanfacine—Phenacemide—Felbamate—epilepsy syndrome	0.171	0.635	CrCrCtD
Guanfacine—ADRA2A—epilepsy syndrome	0.142	0.58	CbGaD
Guanfacine—CYP2C19—epilepsy syndrome	0.103	0.42	CbGaD
Guanfacine—Phenacemide—Lacosamide—epilepsy syndrome	0.0983	0.365	CrCrCtD
Guanfacine—CYP2C19—Oxcarbazepine—epilepsy syndrome	0.0167	0.0526	CbGbCtD
Guanfacine—CYP2C19—Felbamate—epilepsy syndrome	0.0155	0.0489	CbGbCtD
Guanfacine—CYP2C19—Trimethadione—epilepsy syndrome	0.0155	0.0489	CbGbCtD
Guanfacine—CYP2C19—Fosphenytoin—epilepsy syndrome	0.0146	0.046	CbGbCtD
Guanfacine—CYP2C9—Trimethadione—epilepsy syndrome	0.0129	0.0407	CbGbCtD
Guanfacine—CYP2C19—Clobazam—epilepsy syndrome	0.0126	0.0399	CbGbCtD
Guanfacine—CYP2C9—Fosphenytoin—epilepsy syndrome	0.0121	0.0383	CbGbCtD
Guanfacine—CYP2C19—Carbamazepine—epilepsy syndrome	0.0105	0.0331	CbGbCtD
Guanfacine—CYP2C19—Primidone—epilepsy syndrome	0.00978	0.0309	CbGbCtD
Guanfacine—CYP2C19—Phenytoin—epilepsy syndrome	0.00939	0.0297	CbGbCtD
Guanfacine—CYP2C19—Propofol—epilepsy syndrome	0.00876	0.0277	CbGbCtD
Guanfacine—CYP2C9—Carbamazepine—epilepsy syndrome	0.00871	0.0275	CbGbCtD
Guanfacine—CYP2C19—Phenobarbital—epilepsy syndrome	0.00837	0.0264	CbGbCtD
Guanfacine—CYP2C9—Primidone—epilepsy syndrome	0.00813	0.0257	CbGbCtD
Guanfacine—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.00806	0.0255	CbGbCtD
Guanfacine—CYP2C19—Diazepam—epilepsy syndrome	0.00794	0.0251	CbGbCtD
Guanfacine—CYP2C9—Phenytoin—epilepsy syndrome	0.00781	0.0247	CbGbCtD
Guanfacine—CYP2C19—Zonisamide—epilepsy syndrome	0.00775	0.0245	CbGbCtD
Guanfacine—CYP3A4—Trimethadione—epilepsy syndrome	0.00749	0.0237	CbGbCtD
Guanfacine—CYP3A4—Felbamate—epilepsy syndrome	0.00749	0.0237	CbGbCtD
Guanfacine—CYP2C9—Propofol—epilepsy syndrome	0.00728	0.023	CbGbCtD
Guanfacine—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00705	0.0222	CbGbCtD
Guanfacine—CYP2C9—Phenobarbital—epilepsy syndrome	0.00696	0.022	CbGbCtD
Guanfacine—CYP2C9—Diazepam—epilepsy syndrome	0.0066	0.0208	CbGbCtD
Guanfacine—CYP3A4—Clonazepam—epilepsy syndrome	0.00637	0.0201	CbGbCtD
Guanfacine—CYP2C19—Valproic Acid—epilepsy syndrome	0.00626	0.0198	CbGbCtD
Guanfacine—CYP3A4—Clobazam—epilepsy syndrome	0.00611	0.0193	CbGbCtD
Guanfacine—CYP2C19—Topiramate—epilepsy syndrome	0.00564	0.0178	CbGbCtD
Guanfacine—CYP2C9—Valproic Acid—epilepsy syndrome	0.0052	0.0164	CbGbCtD
Guanfacine—CYP3A4—Rufinamide—epilepsy syndrome	0.00519	0.0164	CbGbCtD
Guanfacine—CYP3A4—Carbamazepine—epilepsy syndrome	0.00506	0.016	CbGbCtD
Guanfacine—CYP3A4—Primidone—epilepsy syndrome	0.00473	0.0149	CbGbCtD
Guanfacine—CYP3A4—Phenytoin—epilepsy syndrome	0.00454	0.0143	CbGbCtD
Guanfacine—CYP3A4—Propofol—epilepsy syndrome	0.00423	0.0134	CbGbCtD
Guanfacine—CYP3A4—Acetazolamide—epilepsy syndrome	0.00405	0.0128	CbGbCtD
Guanfacine—CYP3A4—Phenobarbital—epilepsy syndrome	0.00405	0.0128	CbGbCtD
Guanfacine—CYP3A4—Midazolam—epilepsy syndrome	0.00399	0.0126	CbGbCtD
Guanfacine—CYP3A4—Diazepam—epilepsy syndrome	0.00384	0.0121	CbGbCtD
Guanfacine—CYP3A4—Zonisamide—epilepsy syndrome	0.00374	0.0118	CbGbCtD
Guanfacine—CYP3A4—Valproic Acid—epilepsy syndrome	0.00302	0.00955	CbGbCtD
Guanfacine—CYP3A4—Topiramate—epilepsy syndrome	0.00273	0.00862	CbGbCtD
Guanfacine—Phenacemide—SCN1A—epilepsy syndrome	0.000678	0.217	CrCbGaD
Guanfacine—Diclofenac—KCNQ2—epilepsy syndrome	0.000629	0.202	CrCbGaD
Guanfacine—Diclofenac—KCNQ3—epilepsy syndrome	0.000629	0.202	CrCbGaD
Guanfacine—Guanabenz—ADRA2A—epilepsy syndrome	0.000569	0.182	CrCbGaD
Guanfacine—Diclofenac—SCN4A—epilepsy syndrome	0.000381	0.122	CrCbGaD
Guanfacine—Diclofenac—CYP2C19—epilepsy syndrome	8.75e-05	0.028	CrCbGaD
Guanfacine—Diclofenac—PTGS2—epilepsy syndrome	5.45e-05	0.0174	CrCbGaD
Guanfacine—Diclofenac—ALB—epilepsy syndrome	4.85e-05	0.0155	CrCbGaD
Guanfacine—Nausea—Propofol—epilepsy syndrome	4.8e-05	0.000383	CcSEcCtD
Guanfacine—Tension—Gabapentin—epilepsy syndrome	4.79e-05	0.000383	CcSEcCtD
Guanfacine—Vomiting—Fosphenytoin—epilepsy syndrome	4.79e-05	0.000383	CcSEcCtD
Guanfacine—Diarrhoea—Felbamate—epilepsy syndrome	4.78e-05	0.000383	CcSEcCtD
Guanfacine—Vertigo—Pregabalin—epilepsy syndrome	4.78e-05	0.000382	CcSEcCtD
Guanfacine—Abdominal pain—Lamotrigine—epilepsy syndrome	4.78e-05	0.000382	CcSEcCtD
Guanfacine—Dysgeusia—Gabapentin—epilepsy syndrome	4.78e-05	0.000382	CcSEcCtD
Guanfacine—Dizziness—Diazepam—epilepsy syndrome	4.78e-05	0.000382	CcSEcCtD
Guanfacine—Syncope—Pregabalin—epilepsy syndrome	4.77e-05	0.000382	CcSEcCtD
Guanfacine—Rash—Fosphenytoin—epilepsy syndrome	4.75e-05	0.00038	CcSEcCtD
Guanfacine—Dermatitis—Fosphenytoin—epilepsy syndrome	4.74e-05	0.000379	CcSEcCtD
Guanfacine—Nervousness—Gabapentin—epilepsy syndrome	4.74e-05	0.000379	CcSEcCtD
Guanfacine—Asthenia—Clonazepam—epilepsy syndrome	4.73e-05	0.000378	CcSEcCtD
Guanfacine—Rhinitis—Topiramate—epilepsy syndrome	4.73e-05	0.000378	CcSEcCtD
Guanfacine—Headache—Fosphenytoin—epilepsy syndrome	4.72e-05	0.000377	CcSEcCtD
Guanfacine—Palpitations—Pregabalin—epilepsy syndrome	4.7e-05	0.000376	CcSEcCtD
Guanfacine—Asthenia—Phenytoin—epilepsy syndrome	4.7e-05	0.000376	CcSEcCtD
Guanfacine—Nausea—Midazolam—epilepsy syndrome	4.69e-05	0.000375	CcSEcCtD
Guanfacine—Hallucination—Topiramate—epilepsy syndrome	4.69e-05	0.000375	CcSEcCtD
Guanfacine—Muscle spasms—Gabapentin—epilepsy syndrome	4.69e-05	0.000375	CcSEcCtD
Guanfacine—Tachycardia—Valproic Acid—epilepsy syndrome	4.69e-05	0.000375	CcSEcCtD
Guanfacine—Diarrhoea—Zonisamide—epilepsy syndrome	4.68e-05	0.000374	CcSEcCtD
Guanfacine—Loss of consciousness—Pregabalin—epilepsy syndrome	4.68e-05	0.000374	CcSEcCtD
Guanfacine—Asthenia—Oxcarbazepine—epilepsy syndrome	4.68e-05	0.000374	CcSEcCtD
Guanfacine—Pruritus—Clonazepam—epilepsy syndrome	4.67e-05	0.000373	CcSEcCtD
Guanfacine—Vomiting—Vigabatrin—epilepsy syndrome	4.67e-05	0.000373	CcSEcCtD
Guanfacine—Hyperhidrosis—Valproic Acid—epilepsy syndrome	4.64e-05	0.000371	CcSEcCtD
Guanfacine—Pruritus—Phenytoin—epilepsy syndrome	4.64e-05	0.000371	CcSEcCtD
Guanfacine—Nausea—Levetiracetam—epilepsy syndrome	4.63e-05	0.00037	CcSEcCtD
Guanfacine—Diclofenac—ABCB1—epilepsy syndrome	4.63e-05	0.0148	CrCbGaD
Guanfacine—Rash—Vigabatrin—epilepsy syndrome	4.63e-05	0.00037	CcSEcCtD
Guanfacine—Dizziness—Felbamate—epilepsy syndrome	4.62e-05	0.00037	CcSEcCtD
Guanfacine—Dermatitis—Vigabatrin—epilepsy syndrome	4.62e-05	0.00037	CcSEcCtD
Guanfacine—Pruritus—Oxcarbazepine—epilepsy syndrome	4.61e-05	0.000369	CcSEcCtD
Guanfacine—Convulsion—Pregabalin—epilepsy syndrome	4.61e-05	0.000369	CcSEcCtD
Guanfacine—Hypersensitivity—Carbamazepine—epilepsy syndrome	4.61e-05	0.000368	CcSEcCtD
Guanfacine—Vision blurred—Gabapentin—epilepsy syndrome	4.6e-05	0.000368	CcSEcCtD
Guanfacine—Headache—Vigabatrin—epilepsy syndrome	4.6e-05	0.000368	CcSEcCtD
Guanfacine—Hypertension—Pregabalin—epilepsy syndrome	4.59e-05	0.000367	CcSEcCtD
Guanfacine—Vomiting—Diazepam—epilepsy syndrome	4.59e-05	0.000367	CcSEcCtD
Guanfacine—Tremor—Gabapentin—epilepsy syndrome	4.57e-05	0.000365	CcSEcCtD
Guanfacine—Rash—Diazepam—epilepsy syndrome	4.56e-05	0.000364	CcSEcCtD
Guanfacine—Dermatitis—Diazepam—epilepsy syndrome	4.55e-05	0.000364	CcSEcCtD
Guanfacine—Visual impairment—Topiramate—epilepsy syndrome	4.54e-05	0.000363	CcSEcCtD
Guanfacine—Chest pain—Pregabalin—epilepsy syndrome	4.53e-05	0.000362	CcSEcCtD
Guanfacine—Arthralgia—Pregabalin—epilepsy syndrome	4.53e-05	0.000362	CcSEcCtD
Guanfacine—Myalgia—Pregabalin—epilepsy syndrome	4.53e-05	0.000362	CcSEcCtD
Guanfacine—Ill-defined disorder—Gabapentin—epilepsy syndrome	4.53e-05	0.000362	CcSEcCtD
Guanfacine—Dizziness—Zonisamide—epilepsy syndrome	4.53e-05	0.000362	CcSEcCtD
Guanfacine—Headache—Diazepam—epilepsy syndrome	4.53e-05	0.000362	CcSEcCtD
Guanfacine—Anxiety—Pregabalin—epilepsy syndrome	4.51e-05	0.000361	CcSEcCtD
Guanfacine—Diarrhoea—Clonazepam—epilepsy syndrome	4.51e-05	0.000361	CcSEcCtD
Guanfacine—Hypotension—Valproic Acid—epilepsy syndrome	4.49e-05	0.000359	CcSEcCtD
Guanfacine—Asthenia—Carbamazepine—epilepsy syndrome	4.49e-05	0.000359	CcSEcCtD
Guanfacine—Agitation—Gabapentin—epilepsy syndrome	4.48e-05	0.000358	CcSEcCtD
Guanfacine—Diarrhoea—Phenytoin—epilepsy syndrome	4.48e-05	0.000358	CcSEcCtD
Guanfacine—Discomfort—Pregabalin—epilepsy syndrome	4.48e-05	0.000358	CcSEcCtD
Guanfacine—Nausea—Fosphenytoin—epilepsy syndrome	4.47e-05	0.000358	CcSEcCtD
Guanfacine—Diarrhoea—Oxcarbazepine—epilepsy syndrome	4.46e-05	0.000357	CcSEcCtD
Guanfacine—Hypersensitivity—Lamotrigine—epilepsy syndrome	4.45e-05	0.000356	CcSEcCtD
Guanfacine—Vomiting—Felbamate—epilepsy syndrome	4.45e-05	0.000355	CcSEcCtD
Guanfacine—Dry mouth—Pregabalin—epilepsy syndrome	4.43e-05	0.000354	CcSEcCtD
Guanfacine—Pruritus—Carbamazepine—epilepsy syndrome	4.42e-05	0.000354	CcSEcCtD
Guanfacine—Rash—Felbamate—epilepsy syndrome	4.41e-05	0.000353	CcSEcCtD
Guanfacine—Eye disorder—Topiramate—epilepsy syndrome	4.41e-05	0.000352	CcSEcCtD
Guanfacine—Dermatitis—Felbamate—epilepsy syndrome	4.4e-05	0.000352	CcSEcCtD
Guanfacine—Malaise—Gabapentin—epilepsy syndrome	4.4e-05	0.000352	CcSEcCtD
Guanfacine—Tinnitus—Topiramate—epilepsy syndrome	4.4e-05	0.000352	CcSEcCtD
Guanfacine—Vertigo—Gabapentin—epilepsy syndrome	4.38e-05	0.00035	CcSEcCtD
Guanfacine—Headache—Felbamate—epilepsy syndrome	4.38e-05	0.00035	CcSEcCtD
Guanfacine—Confusional state—Pregabalin—epilepsy syndrome	4.38e-05	0.00035	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	4.38e-05	0.00035	CcSEcCtD
Guanfacine—Syncope—Gabapentin—epilepsy syndrome	4.38e-05	0.00035	CcSEcCtD
Guanfacine—Dizziness—Clonazepam—epilepsy syndrome	4.36e-05	0.000349	CcSEcCtD
Guanfacine—Nausea—Vigabatrin—epilepsy syndrome	4.36e-05	0.000349	CcSEcCtD
Guanfacine—Vomiting—Zonisamide—epilepsy syndrome	4.35e-05	0.000348	CcSEcCtD
Guanfacine—Insomnia—Valproic Acid—epilepsy syndrome	4.34e-05	0.000347	CcSEcCtD
Guanfacine—Oedema—Pregabalin—epilepsy syndrome	4.34e-05	0.000347	CcSEcCtD
Guanfacine—Asthenia—Lamotrigine—epilepsy syndrome	4.34e-05	0.000347	CcSEcCtD
Guanfacine—Dizziness—Phenytoin—epilepsy syndrome	4.33e-05	0.000346	CcSEcCtD
Guanfacine—Rash—Zonisamide—epilepsy syndrome	4.32e-05	0.000345	CcSEcCtD
Guanfacine—Paraesthesia—Valproic Acid—epilepsy syndrome	4.31e-05	0.000345	CcSEcCtD
Guanfacine—Palpitations—Gabapentin—epilepsy syndrome	4.31e-05	0.000345	CcSEcCtD
Guanfacine—Dermatitis—Zonisamide—epilepsy syndrome	4.31e-05	0.000345	CcSEcCtD
Guanfacine—Dizziness—Oxcarbazepine—epilepsy syndrome	4.31e-05	0.000345	CcSEcCtD
Guanfacine—Nausea—Diazepam—epilepsy syndrome	4.29e-05	0.000343	CcSEcCtD
Guanfacine—Loss of consciousness—Gabapentin—epilepsy syndrome	4.29e-05	0.000343	CcSEcCtD
Guanfacine—Headache—Zonisamide—epilepsy syndrome	4.29e-05	0.000343	CcSEcCtD
Guanfacine—Dyspnoea—Valproic Acid—epilepsy syndrome	4.28e-05	0.000342	CcSEcCtD
Guanfacine—Diarrhoea—Carbamazepine—epilepsy syndrome	4.28e-05	0.000342	CcSEcCtD
Guanfacine—Pruritus—Lamotrigine—epilepsy syndrome	4.28e-05	0.000342	CcSEcCtD
Guanfacine—Shock—Pregabalin—epilepsy syndrome	4.27e-05	0.000342	CcSEcCtD
Guanfacine—Somnolence—Valproic Acid—epilepsy syndrome	4.27e-05	0.000341	CcSEcCtD
Guanfacine—Immune system disorder—Topiramate—epilepsy syndrome	4.26e-05	0.000341	CcSEcCtD
Guanfacine—Tachycardia—Pregabalin—epilepsy syndrome	4.24e-05	0.000339	CcSEcCtD
Guanfacine—Dyspepsia—Valproic Acid—epilepsy syndrome	4.23e-05	0.000338	CcSEcCtD
Guanfacine—Convulsion—Gabapentin—epilepsy syndrome	4.23e-05	0.000338	CcSEcCtD
Guanfacine—Hypertension—Gabapentin—epilepsy syndrome	4.21e-05	0.000337	CcSEcCtD
Guanfacine—Hyperhidrosis—Pregabalin—epilepsy syndrome	4.2e-05	0.000336	CcSEcCtD
Guanfacine—Vomiting—Clonazepam—epilepsy syndrome	4.19e-05	0.000335	CcSEcCtD
Guanfacine—Decreased appetite—Valproic Acid—epilepsy syndrome	4.18e-05	0.000334	CcSEcCtD
Guanfacine—Alopecia—Topiramate—epilepsy syndrome	4.17e-05	0.000333	CcSEcCtD
Guanfacine—Vomiting—Phenytoin—epilepsy syndrome	4.17e-05	0.000333	CcSEcCtD
Guanfacine—Rash—Clonazepam—epilepsy syndrome	4.16e-05	0.000333	CcSEcCtD
Guanfacine—Dermatitis—Clonazepam—epilepsy syndrome	4.16e-05	0.000332	CcSEcCtD
Guanfacine—Myalgia—Gabapentin—epilepsy syndrome	4.15e-05	0.000332	CcSEcCtD
Guanfacine—Arthralgia—Gabapentin—epilepsy syndrome	4.15e-05	0.000332	CcSEcCtD
Guanfacine—Chest pain—Gabapentin—epilepsy syndrome	4.15e-05	0.000332	CcSEcCtD
Guanfacine—Nausea—Felbamate—epilepsy syndrome	4.15e-05	0.000332	CcSEcCtD
Guanfacine—Vomiting—Oxcarbazepine—epilepsy syndrome	4.14e-05	0.000331	CcSEcCtD
Guanfacine—Fatigue—Valproic Acid—epilepsy syndrome	4.14e-05	0.000331	CcSEcCtD
Guanfacine—Anxiety—Gabapentin—epilepsy syndrome	4.14e-05	0.000331	CcSEcCtD
Guanfacine—Dizziness—Carbamazepine—epilepsy syndrome	4.14e-05	0.000331	CcSEcCtD
Guanfacine—Diarrhoea—Lamotrigine—epilepsy syndrome	4.14e-05	0.000331	CcSEcCtD
Guanfacine—Headache—Clonazepam—epilepsy syndrome	4.13e-05	0.00033	CcSEcCtD
Guanfacine—Rash—Phenytoin—epilepsy syndrome	4.13e-05	0.00033	CcSEcCtD
Guanfacine—Dermatitis—Phenytoin—epilepsy syndrome	4.13e-05	0.00033	CcSEcCtD
Guanfacine—Rash—Oxcarbazepine—epilepsy syndrome	4.11e-05	0.000329	CcSEcCtD
Guanfacine—Constipation—Valproic Acid—epilepsy syndrome	4.11e-05	0.000328	CcSEcCtD
Guanfacine—Dermatitis—Oxcarbazepine—epilepsy syndrome	4.11e-05	0.000328	CcSEcCtD
Guanfacine—Headache—Phenytoin—epilepsy syndrome	4.1e-05	0.000328	CcSEcCtD
Guanfacine—Discomfort—Gabapentin—epilepsy syndrome	4.1e-05	0.000328	CcSEcCtD
Guanfacine—Headache—Oxcarbazepine—epilepsy syndrome	4.08e-05	0.000326	CcSEcCtD
Guanfacine—Nausea—Zonisamide—epilepsy syndrome	4.07e-05	0.000325	CcSEcCtD
Guanfacine—Dry mouth—Gabapentin—epilepsy syndrome	4.06e-05	0.000325	CcSEcCtD
Guanfacine—Hypotension—Pregabalin—epilepsy syndrome	4.06e-05	0.000324	CcSEcCtD
Guanfacine—Tension—Topiramate—epilepsy syndrome	4.03e-05	0.000322	CcSEcCtD
Guanfacine—Dysgeusia—Topiramate—epilepsy syndrome	4.02e-05	0.000321	CcSEcCtD
Guanfacine—Confusional state—Gabapentin—epilepsy syndrome	4.01e-05	0.000321	CcSEcCtD
Guanfacine—Dizziness—Lamotrigine—epilepsy syndrome	4e-05	0.00032	CcSEcCtD
Guanfacine—Nervousness—Topiramate—epilepsy syndrome	3.99e-05	0.000319	CcSEcCtD
Guanfacine—Oedema—Gabapentin—epilepsy syndrome	3.98e-05	0.000318	CcSEcCtD
Guanfacine—Vomiting—Carbamazepine—epilepsy syndrome	3.98e-05	0.000318	CcSEcCtD
Guanfacine—Feeling abnormal—Valproic Acid—epilepsy syndrome	3.96e-05	0.000316	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	3.96e-05	0.000316	CcSEcCtD
Guanfacine—Muscle spasms—Topiramate—epilepsy syndrome	3.95e-05	0.000316	CcSEcCtD
Guanfacine—Rash—Carbamazepine—epilepsy syndrome	3.94e-05	0.000315	CcSEcCtD
Guanfacine—Dermatitis—Carbamazepine—epilepsy syndrome	3.94e-05	0.000315	CcSEcCtD
Guanfacine—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	3.93e-05	0.000314	CcSEcCtD
Guanfacine—Insomnia—Pregabalin—epilepsy syndrome	3.93e-05	0.000314	CcSEcCtD
Guanfacine—Nausea—Clonazepam—epilepsy syndrome	3.92e-05	0.000313	CcSEcCtD
Guanfacine—Headache—Carbamazepine—epilepsy syndrome	3.92e-05	0.000313	CcSEcCtD
Guanfacine—Shock—Gabapentin—epilepsy syndrome	3.92e-05	0.000313	CcSEcCtD
Guanfacine—Paraesthesia—Pregabalin—epilepsy syndrome	3.9e-05	0.000312	CcSEcCtD
Guanfacine—Nausea—Phenytoin—epilepsy syndrome	3.89e-05	0.000311	CcSEcCtD
Guanfacine—Tachycardia—Gabapentin—epilepsy syndrome	3.89e-05	0.000311	CcSEcCtD
Guanfacine—Dyspnoea—Pregabalin—epilepsy syndrome	3.87e-05	0.00031	CcSEcCtD
Guanfacine—Nausea—Oxcarbazepine—epilepsy syndrome	3.87e-05	0.00031	CcSEcCtD
Guanfacine—Vision blurred—Topiramate—epilepsy syndrome	3.87e-05	0.000309	CcSEcCtD
Guanfacine—Somnolence—Pregabalin—epilepsy syndrome	3.86e-05	0.000309	CcSEcCtD
Guanfacine—Hyperhidrosis—Gabapentin—epilepsy syndrome	3.85e-05	0.000308	CcSEcCtD
Guanfacine—Tremor—Topiramate—epilepsy syndrome	3.85e-05	0.000307	CcSEcCtD
Guanfacine—Vomiting—Lamotrigine—epilepsy syndrome	3.84e-05	0.000307	CcSEcCtD
Guanfacine—Rash—Lamotrigine—epilepsy syndrome	3.81e-05	0.000305	CcSEcCtD
Guanfacine—Ill-defined disorder—Topiramate—epilepsy syndrome	3.81e-05	0.000305	CcSEcCtD
Guanfacine—Dermatitis—Lamotrigine—epilepsy syndrome	3.81e-05	0.000304	CcSEcCtD
Guanfacine—Abdominal pain—Valproic Acid—epilepsy syndrome	3.8e-05	0.000304	CcSEcCtD
Guanfacine—Headache—Lamotrigine—epilepsy syndrome	3.79e-05	0.000303	CcSEcCtD
Guanfacine—Decreased appetite—Pregabalin—epilepsy syndrome	3.77e-05	0.000302	CcSEcCtD
Guanfacine—Agitation—Topiramate—epilepsy syndrome	3.77e-05	0.000302	CcSEcCtD
Guanfacine—Fatigue—Pregabalin—epilepsy syndrome	3.74e-05	0.000299	CcSEcCtD
Guanfacine—Hypotension—Gabapentin—epilepsy syndrome	3.72e-05	0.000297	CcSEcCtD
Guanfacine—Nausea—Carbamazepine—epilepsy syndrome	3.71e-05	0.000297	CcSEcCtD
Guanfacine—Constipation—Pregabalin—epilepsy syndrome	3.71e-05	0.000297	CcSEcCtD
Guanfacine—Malaise—Topiramate—epilepsy syndrome	3.7e-05	0.000296	CcSEcCtD
Guanfacine—Vertigo—Topiramate—epilepsy syndrome	3.69e-05	0.000295	CcSEcCtD
Guanfacine—Syncope—Topiramate—epilepsy syndrome	3.68e-05	0.000294	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	3.63e-05	0.00029	CcSEcCtD
Guanfacine—Palpitations—Topiramate—epilepsy syndrome	3.63e-05	0.00029	CcSEcCtD
Guanfacine—Loss of consciousness—Topiramate—epilepsy syndrome	3.61e-05	0.000288	CcSEcCtD
Guanfacine—Insomnia—Gabapentin—epilepsy syndrome	3.6e-05	0.000288	CcSEcCtD
Guanfacine—Nausea—Lamotrigine—epilepsy syndrome	3.59e-05	0.000287	CcSEcCtD
Guanfacine—Feeling abnormal—Pregabalin—epilepsy syndrome	3.58e-05	0.000286	CcSEcCtD
Guanfacine—Paraesthesia—Gabapentin—epilepsy syndrome	3.58e-05	0.000286	CcSEcCtD
Guanfacine—Convulsion—Topiramate—epilepsy syndrome	3.56e-05	0.000284	CcSEcCtD
Guanfacine—Gastrointestinal pain—Pregabalin—epilepsy syndrome	3.55e-05	0.000284	CcSEcCtD
Guanfacine—Dyspnoea—Gabapentin—epilepsy syndrome	3.55e-05	0.000284	CcSEcCtD
Guanfacine—Hypertension—Topiramate—epilepsy syndrome	3.54e-05	0.000283	CcSEcCtD
Guanfacine—Somnolence—Gabapentin—epilepsy syndrome	3.54e-05	0.000283	CcSEcCtD
Guanfacine—Hypersensitivity—Valproic Acid—epilepsy syndrome	3.54e-05	0.000283	CcSEcCtD
Guanfacine—Dyspepsia—Gabapentin—epilepsy syndrome	3.5e-05	0.00028	CcSEcCtD
Guanfacine—Myalgia—Topiramate—epilepsy syndrome	3.49e-05	0.000279	CcSEcCtD
Guanfacine—Chest pain—Topiramate—epilepsy syndrome	3.49e-05	0.000279	CcSEcCtD
Guanfacine—Arthralgia—Topiramate—epilepsy syndrome	3.49e-05	0.000279	CcSEcCtD
Guanfacine—Anxiety—Topiramate—epilepsy syndrome	3.48e-05	0.000278	CcSEcCtD
Guanfacine—Decreased appetite—Gabapentin—epilepsy syndrome	3.46e-05	0.000277	CcSEcCtD
Guanfacine—Discomfort—Topiramate—epilepsy syndrome	3.45e-05	0.000276	CcSEcCtD
Guanfacine—Asthenia—Valproic Acid—epilepsy syndrome	3.45e-05	0.000276	CcSEcCtD
Guanfacine—Fatigue—Gabapentin—epilepsy syndrome	3.43e-05	0.000274	CcSEcCtD
Guanfacine—Abdominal pain—Pregabalin—epilepsy syndrome	3.43e-05	0.000274	CcSEcCtD
Guanfacine—Dry mouth—Topiramate—epilepsy syndrome	3.42e-05	0.000273	CcSEcCtD
Guanfacine—Constipation—Gabapentin—epilepsy syndrome	3.4e-05	0.000272	CcSEcCtD
Guanfacine—Pruritus—Valproic Acid—epilepsy syndrome	3.4e-05	0.000272	CcSEcCtD
Guanfacine—Confusional state—Topiramate—epilepsy syndrome	3.38e-05	0.00027	CcSEcCtD
Guanfacine—Oedema—Topiramate—epilepsy syndrome	3.35e-05	0.000268	CcSEcCtD
Guanfacine—Shock—Topiramate—epilepsy syndrome	3.3e-05	0.000264	CcSEcCtD
Guanfacine—Diarrhoea—Valproic Acid—epilepsy syndrome	3.29e-05	0.000263	CcSEcCtD
Guanfacine—Feeling abnormal—Gabapentin—epilepsy syndrome	3.28e-05	0.000262	CcSEcCtD
Guanfacine—Tachycardia—Topiramate—epilepsy syndrome	3.27e-05	0.000261	CcSEcCtD
Guanfacine—Gastrointestinal pain—Gabapentin—epilepsy syndrome	3.26e-05	0.00026	CcSEcCtD
Guanfacine—Hyperhidrosis—Topiramate—epilepsy syndrome	3.24e-05	0.000259	CcSEcCtD
Guanfacine—Hypersensitivity—Pregabalin—epilepsy syndrome	3.2e-05	0.000256	CcSEcCtD
Guanfacine—Dizziness—Valproic Acid—epilepsy syndrome	3.18e-05	0.000254	CcSEcCtD
Guanfacine—Abdominal pain—Gabapentin—epilepsy syndrome	3.15e-05	0.000252	CcSEcCtD
Guanfacine—Hypotension—Topiramate—epilepsy syndrome	3.13e-05	0.00025	CcSEcCtD
Guanfacine—Asthenia—Pregabalin—epilepsy syndrome	3.12e-05	0.000249	CcSEcCtD
Guanfacine—Pruritus—Pregabalin—epilepsy syndrome	3.07e-05	0.000246	CcSEcCtD
Guanfacine—Vomiting—Valproic Acid—epilepsy syndrome	3.05e-05	0.000244	CcSEcCtD
Guanfacine—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	3.05e-05	0.000244	CcSEcCtD
Guanfacine—Insomnia—Topiramate—epilepsy syndrome	3.03e-05	0.000242	CcSEcCtD
Guanfacine—Rash—Valproic Acid—epilepsy syndrome	3.03e-05	0.000242	CcSEcCtD
Guanfacine—Dermatitis—Valproic Acid—epilepsy syndrome	3.03e-05	0.000242	CcSEcCtD
Guanfacine—Headache—Valproic Acid—epilepsy syndrome	3.01e-05	0.000241	CcSEcCtD
Guanfacine—Paraesthesia—Topiramate—epilepsy syndrome	3.01e-05	0.000241	CcSEcCtD
Guanfacine—Dyspnoea—Topiramate—epilepsy syndrome	2.99e-05	0.000239	CcSEcCtD
Guanfacine—Somnolence—Topiramate—epilepsy syndrome	2.98e-05	0.000238	CcSEcCtD
Guanfacine—Diarrhoea—Pregabalin—epilepsy syndrome	2.97e-05	0.000238	CcSEcCtD
Guanfacine—Dyspepsia—Topiramate—epilepsy syndrome	2.95e-05	0.000236	CcSEcCtD
Guanfacine—Hypersensitivity—Gabapentin—epilepsy syndrome	2.93e-05	0.000235	CcSEcCtD
Guanfacine—Decreased appetite—Topiramate—epilepsy syndrome	2.91e-05	0.000233	CcSEcCtD
Guanfacine—Fatigue—Topiramate—epilepsy syndrome	2.89e-05	0.000231	CcSEcCtD
Guanfacine—Dizziness—Pregabalin—epilepsy syndrome	2.87e-05	0.00023	CcSEcCtD
Guanfacine—Constipation—Topiramate—epilepsy syndrome	2.86e-05	0.000229	CcSEcCtD
Guanfacine—Asthenia—Gabapentin—epilepsy syndrome	2.86e-05	0.000228	CcSEcCtD
Guanfacine—Nausea—Valproic Acid—epilepsy syndrome	2.85e-05	0.000228	CcSEcCtD
Guanfacine—Pruritus—Gabapentin—epilepsy syndrome	2.82e-05	0.000225	CcSEcCtD
Guanfacine—Vomiting—Pregabalin—epilepsy syndrome	2.76e-05	0.000221	CcSEcCtD
Guanfacine—Feeling abnormal—Topiramate—epilepsy syndrome	2.76e-05	0.000221	CcSEcCtD
Guanfacine—Gastrointestinal pain—Topiramate—epilepsy syndrome	2.74e-05	0.000219	CcSEcCtD
Guanfacine—Rash—Pregabalin—epilepsy syndrome	2.74e-05	0.000219	CcSEcCtD
Guanfacine—Dermatitis—Pregabalin—epilepsy syndrome	2.74e-05	0.000219	CcSEcCtD
Guanfacine—Diarrhoea—Gabapentin—epilepsy syndrome	2.72e-05	0.000218	CcSEcCtD
Guanfacine—Headache—Pregabalin—epilepsy syndrome	2.72e-05	0.000218	CcSEcCtD
Guanfacine—Abdominal pain—Topiramate—epilepsy syndrome	2.65e-05	0.000212	CcSEcCtD
Guanfacine—Dizziness—Gabapentin—epilepsy syndrome	2.63e-05	0.000211	CcSEcCtD
Guanfacine—Nausea—Pregabalin—epilepsy syndrome	2.58e-05	0.000206	CcSEcCtD
Guanfacine—Vomiting—Gabapentin—epilepsy syndrome	2.53e-05	0.000202	CcSEcCtD
Guanfacine—Rash—Gabapentin—epilepsy syndrome	2.51e-05	0.000201	CcSEcCtD
Guanfacine—Dermatitis—Gabapentin—epilepsy syndrome	2.51e-05	0.000201	CcSEcCtD
Guanfacine—Headache—Gabapentin—epilepsy syndrome	2.49e-05	0.000199	CcSEcCtD
Guanfacine—Hypersensitivity—Topiramate—epilepsy syndrome	2.47e-05	0.000197	CcSEcCtD
Guanfacine—Asthenia—Topiramate—epilepsy syndrome	2.4e-05	0.000192	CcSEcCtD
Guanfacine—Pruritus—Topiramate—epilepsy syndrome	2.37e-05	0.00019	CcSEcCtD
Guanfacine—Nausea—Gabapentin—epilepsy syndrome	2.37e-05	0.000189	CcSEcCtD
Guanfacine—Diarrhoea—Topiramate—epilepsy syndrome	2.29e-05	0.000183	CcSEcCtD
Guanfacine—Dizziness—Topiramate—epilepsy syndrome	2.22e-05	0.000177	CcSEcCtD
Guanfacine—Vomiting—Topiramate—epilepsy syndrome	2.13e-05	0.00017	CcSEcCtD
Guanfacine—Rash—Topiramate—epilepsy syndrome	2.11e-05	0.000169	CcSEcCtD
Guanfacine—Dermatitis—Topiramate—epilepsy syndrome	2.11e-05	0.000169	CcSEcCtD
Guanfacine—Headache—Topiramate—epilepsy syndrome	2.1e-05	0.000168	CcSEcCtD
Guanfacine—Nausea—Topiramate—epilepsy syndrome	1.99e-05	0.000159	CcSEcCtD
Guanfacine—ADRA2A—Signaling Pathways—CHRM2—epilepsy syndrome	5.99e-06	0.000146	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PTK2B—epilepsy syndrome	5.98e-06	0.000146	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—TSC1—epilepsy syndrome	5.98e-06	0.000146	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—ALB—epilepsy syndrome	5.98e-06	0.000146	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—AQP1—epilepsy syndrome	5.97e-06	0.000145	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	5.92e-06	0.000144	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	5.92e-06	0.000144	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	5.92e-06	0.000144	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PFKL—epilepsy syndrome	5.92e-06	0.000144	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	5.92e-06	0.000144	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—AGT—epilepsy syndrome	5.9e-06	0.000143	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—CDC42—epilepsy syndrome	5.85e-06	0.000142	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—GABBR1—epilepsy syndrome	5.83e-06	0.000142	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—SST—epilepsy syndrome	5.82e-06	0.000142	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—NTRK2—epilepsy syndrome	5.82e-06	0.000142	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CCR2—epilepsy syndrome	5.82e-06	0.000142	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—DUSP6—epilepsy syndrome	5.77e-06	0.00014	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	5.73e-06	0.00014	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—ADRA2A—epilepsy syndrome	5.7e-06	0.000139	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PLAT—epilepsy syndrome	5.67e-06	0.000138	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—AVP—epilepsy syndrome	5.67e-06	0.000138	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—TXNRD1—epilepsy syndrome	5.61e-06	0.000136	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—HRH3—epilepsy syndrome	5.59e-06	0.000136	CbGpPWpGaD
Guanfacine—ADRA2B—Hemostasis—SRC—epilepsy syndrome	5.58e-06	0.000136	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—OPRM1—epilepsy syndrome	5.5e-06	0.000134	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CXCL12—epilepsy syndrome	5.47e-06	0.000133	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—BDKRB2—epilepsy syndrome	5.47e-06	0.000133	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—POMC—epilepsy syndrome	5.46e-06	0.000133	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—PRKCB—epilepsy syndrome	5.45e-06	0.000133	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—AQP1—epilepsy syndrome	5.44e-06	0.000132	CbGpPWpGaD
Guanfacine—ADRA2B—Hemostasis—VEGFA—epilepsy syndrome	5.43e-06	0.000132	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—CYP2D6—epilepsy syndrome	5.43e-06	0.000132	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—IL6ST—epilepsy syndrome	5.43e-06	0.000132	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—UPB1—epilepsy syndrome	5.42e-06	0.000132	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ATIC—epilepsy syndrome	5.42e-06	0.000132	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—NEU1—epilepsy syndrome	5.42e-06	0.000132	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CHRM3—epilepsy syndrome	5.4e-06	0.000131	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—KCNJ11—epilepsy syndrome	5.4e-06	0.000131	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CNR1—epilepsy syndrome	5.37e-06	0.000131	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—JUNB—epilepsy syndrome	5.37e-06	0.000131	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PLCB1—epilepsy syndrome	5.35e-06	0.00013	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—CCR5—epilepsy syndrome	5.3e-06	0.000129	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—HTR7—epilepsy syndrome	5.24e-06	0.000128	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—epilepsy syndrome	5.23e-06	0.000127	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	5.22e-06	0.000127	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CCR3—epilepsy syndrome	5.19e-06	0.000126	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—HTR2A—epilepsy syndrome	5.19e-06	0.000126	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—BCHE—epilepsy syndrome	5.15e-06	0.000125	CbGpPWpGaD
Guanfacine—ADRA2A—Platelet activation, signaling and aggregation—AKT1—epilepsy syndrome	5.1e-06	0.000124	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—HBEGF—epilepsy syndrome	5.09e-06	0.000124	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NPY—epilepsy syndrome	5.06e-06	0.000123	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—ATP2A2—epilepsy syndrome	5.06e-06	0.000123	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	5.04e-06	0.000123	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GBE1—epilepsy syndrome	5.04e-06	0.000123	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	5.03e-06	0.000122	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—AKT3—epilepsy syndrome	4.99e-06	0.000122	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—POMC—epilepsy syndrome	4.96e-06	0.000121	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—AGT—epilepsy syndrome	4.93e-06	0.00012	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.93e-06	0.00012	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—KCNJ11—epilepsy syndrome	4.92e-06	0.00012	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CHRM3—epilepsy syndrome	4.92e-06	0.00012	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—SLC2A1—epilepsy syndrome	4.91e-06	0.000119	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—HSPB1—epilepsy syndrome	4.88e-06	0.000119	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—OXT—epilepsy syndrome	4.88e-06	0.000119	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CRH—epilepsy syndrome	4.88e-06	0.000119	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CXCL2—epilepsy syndrome	4.88e-06	0.000119	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CCL3—epilepsy syndrome	4.88e-06	0.000119	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—ADAM10—epilepsy syndrome	4.88e-06	0.000119	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PLCB1—epilepsy syndrome	4.86e-06	0.000118	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—CCL2—epilepsy syndrome	4.86e-06	0.000118	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—TH—epilepsy syndrome	4.84e-06	0.000118	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—CCR5—epilepsy syndrome	4.82e-06	0.000117	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	4.74e-06	0.000115	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—HTR2A—epilepsy syndrome	4.71e-06	0.000115	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—S100B—epilepsy syndrome	4.61e-06	0.000112	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	4.61e-06	0.000112	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—AGT—epilepsy syndrome	4.58e-06	0.000112	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—SOCS3—epilepsy syndrome	4.57e-06	0.000111	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CDC42—epilepsy syndrome	4.56e-06	0.000111	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—PRKCB—epilepsy syndrome	4.55e-06	0.000111	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PTK2B—epilepsy syndrome	4.54e-06	0.00011	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—TSC1—epilepsy syndrome	4.54e-06	0.00011	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—epilepsy syndrome	4.49e-06	0.000109	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—NT5E—epilepsy syndrome	4.49e-06	0.000109	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ALAD—epilepsy syndrome	4.49e-06	0.000109	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—AGT—epilepsy syndrome	4.47e-06	0.000109	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CCR2—epilepsy syndrome	4.42e-06	0.000107	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—SST—epilepsy syndrome	4.42e-06	0.000107	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NTRK2—epilepsy syndrome	4.42e-06	0.000107	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—AVP—epilepsy syndrome	4.41e-06	0.000107	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—ABCG2—epilepsy syndrome	4.4e-06	0.000107	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—DUSP6—epilepsy syndrome	4.38e-06	0.000107	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PLAT—epilepsy syndrome	4.3e-06	0.000105	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	4.28e-06	0.000104	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	4.28e-06	0.000104	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CYP11A1—epilepsy syndrome	4.26e-06	0.000104	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—SRC—epilepsy syndrome	4.23e-06	0.000103	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	4.23e-06	0.000103	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	4.19e-06	0.000102	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—HES1—epilepsy syndrome	4.17e-06	0.000102	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CXCL12—epilepsy syndrome	4.15e-06	0.000101	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—BDKRB2—epilepsy syndrome	4.15e-06	0.000101	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—POMC—epilepsy syndrome	4.15e-06	0.000101	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—PRKCB—epilepsy syndrome	4.13e-06	0.000101	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—VEGFA—epilepsy syndrome	4.12e-06	0.0001	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—IL6ST—epilepsy syndrome	4.12e-06	0.0001	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ADSL—epilepsy syndrome	4.11e-06	9.99e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—JUNB—epilepsy syndrome	4.08e-06	9.92e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CNR1—epilepsy syndrome	4.08e-06	9.92e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PLCB1—epilepsy syndrome	4.06e-06	9.88e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—FYN—epilepsy syndrome	4.06e-06	9.87e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—H2AFX—epilepsy syndrome	4.04e-06	9.84e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—HMOX1—epilepsy syndrome	4.04e-06	9.83e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MEF2C—epilepsy syndrome	4.03e-06	9.82e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GLUL—epilepsy syndrome	4.03e-06	9.8e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ABCG2—epilepsy syndrome	4.01e-06	9.76e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—CAT—epilepsy syndrome	3.99e-06	9.7e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—HTR7—epilepsy syndrome	3.98e-06	9.68e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	3.95e-06	9.62e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CYP2C19—epilepsy syndrome	3.91e-06	9.52e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—YWHAZ—epilepsy syndrome	3.9e-06	9.49e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CYP11A1—epilepsy syndrome	3.89e-06	9.46e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—ABCB1—epilepsy syndrome	3.88e-06	9.43e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—HBEGF—epilepsy syndrome	3.86e-06	9.39e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	3.86e-06	9.39e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.86e-06	9.39e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—NGF—epilepsy syndrome	3.86e-06	9.38e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CYP2D6—epilepsy syndrome	3.85e-06	9.36e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—AKT3—epilepsy syndrome	3.79e-06	9.22e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—POMC—epilepsy syndrome	3.77e-06	9.16e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CCR5—epilepsy syndrome	3.75e-06	9.13e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—ADAM10—epilepsy syndrome	3.7e-06	9.01e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	3.7e-06	9e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—CCL2—epilepsy syndrome	3.68e-06	8.96e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—HTR2A—epilepsy syndrome	3.67e-06	8.93e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—ADRA2A—epilepsy syndrome	3.66e-06	8.91e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—BCHE—epilepsy syndrome	3.65e-06	8.87e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—GPX1—epilepsy syndrome	3.6e-06	8.77e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—AQP1—epilepsy syndrome	3.59e-06	8.73e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	3.52e-06	8.56e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CYP2D6—epilepsy syndrome	3.51e-06	8.53e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—S100B—epilepsy syndrome	3.5e-06	8.52e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—TSC2—epilepsy syndrome	3.49e-06	8.49e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—AGT—epilepsy syndrome	3.48e-06	8.47e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—SLC2A1—epilepsy syndrome	3.48e-06	8.46e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Hemostasis—AKT1—epilepsy syndrome	3.47e-06	8.43e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—SOCS3—epilepsy syndrome	3.47e-06	8.43e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CDC42—epilepsy syndrome	3.46e-06	8.41e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PLCB1—epilepsy syndrome	3.44e-06	8.37e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—TH—epilepsy syndrome	3.43e-06	8.34e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—APOE—epilepsy syndrome	3.41e-06	8.3e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.38e-06	8.21e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—AVP—epilepsy syndrome	3.35e-06	8.14e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—KDR—epilepsy syndrome	3.34e-06	8.14e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ADRA2A—epilepsy syndrome	3.34e-06	8.12e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—BCHE—epilepsy syndrome	3.32e-06	8.09e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	3.25e-06	7.9e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	3.25e-06	7.9e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—PRKCB—epilepsy syndrome	3.22e-06	7.83e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—IL6ST—epilepsy syndrome	3.21e-06	7.8e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—SLC2A1—epilepsy syndrome	3.17e-06	7.72e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—HES1—epilepsy syndrome	3.16e-06	7.7e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—AGT—epilepsy syndrome	3.16e-06	7.69e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PLCB1—epilepsy syndrome	3.14e-06	7.63e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—TH—epilepsy syndrome	3.13e-06	7.61e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—APOE—epilepsy syndrome	3.1e-06	7.53e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—FYN—epilepsy syndrome	3.08e-06	7.49e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	3.08e-06	7.49e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—H2AFX—epilepsy syndrome	3.07e-06	7.46e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MEF2C—epilepsy syndrome	3.06e-06	7.45e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—YWHAZ—epilepsy syndrome	2.96e-06	7.2e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—POMC—epilepsy syndrome	2.93e-06	7.13e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—NGF—epilepsy syndrome	2.93e-06	7.12e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CCL2—epilepsy syndrome	2.87e-06	6.98e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—HMOX1—epilepsy syndrome	2.86e-06	6.96e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CCR5—epilepsy syndrome	2.85e-06	6.92e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—CAT—epilepsy syndrome	2.82e-06	6.87e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—HTR2A—epilepsy syndrome	2.78e-06	6.78e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—ABCB1—epilepsy syndrome	2.75e-06	6.68e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—POMC—epilepsy syndrome	2.66e-06	6.47e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	2.65e-06	6.44e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—TSC2—epilepsy syndrome	2.65e-06	6.44e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—AGT—epilepsy syndrome	2.64e-06	6.43e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Hemostasis—AKT1—epilepsy syndrome	2.63e-06	6.4e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—HMOX1—epilepsy syndrome	2.61e-06	6.35e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—FGF2—epilepsy syndrome	2.59e-06	6.31e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—APOE—epilepsy syndrome	2.59e-06	6.3e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	2.58e-06	6.28e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—CAT—epilepsy syndrome	2.57e-06	6.26e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	2.56e-06	6.24e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—GPX1—epilepsy syndrome	2.55e-06	6.21e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—KDR—epilepsy syndrome	2.54e-06	6.17e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ABCB1—epilepsy syndrome	2.5e-06	6.09e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—PRKCB—epilepsy syndrome	2.44e-06	5.94e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—IL6ST—epilepsy syndrome	2.43e-06	5.92e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—ALB—epilepsy syndrome	2.43e-06	5.9e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—RELA—epilepsy syndrome	2.41e-06	5.86e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MTOR—epilepsy syndrome	2.36e-06	5.74e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—GPX1—epilepsy syndrome	2.33e-06	5.67e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	2.31e-06	5.63e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—AGT—epilepsy syndrome	2.24e-06	5.45e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—POMC—epilepsy syndrome	2.22e-06	5.41e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	2.2e-06	5.36e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—APOE—epilepsy syndrome	2.19e-06	5.34e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—BCHE—epilepsy syndrome	2.19e-06	5.34e-05	CbGpPWpGaD
Guanfacine—ADRA2B—GPCR downstream signaling—AKT1—epilepsy syndrome	2.19e-06	5.33e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CCL2—epilepsy syndrome	2.18e-06	5.3e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—CASP3—epilepsy syndrome	2.17e-06	5.28e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—PTGS2—epilepsy syndrome	2.12e-06	5.16e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—JUN—epilepsy syndrome	2.11e-06	5.13e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	2.09e-06	5.09e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	2.07e-06	5.03e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—TH—epilepsy syndrome	2.06e-06	5.02e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—MMP9—epilepsy syndrome	2.05e-06	4.99e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—AGT—epilepsy syndrome	2.04e-06	4.97e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—APOE—epilepsy syndrome	2e-06	4.87e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling by GPCR—AKT1—epilepsy syndrome	1.99e-06	4.84e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—FGF2—epilepsy syndrome	1.97e-06	4.79e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—SRC—epilepsy syndrome	1.89e-06	4.6e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—POMC—epilepsy syndrome	1.88e-06	4.59e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—VEGFA—epilepsy syndrome	1.84e-06	4.48e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—RELA—epilepsy syndrome	1.83e-06	4.44e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MTOR—epilepsy syndrome	1.79e-06	4.36e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.72e-06	4.19e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—POMC—epilepsy syndrome	1.72e-06	4.18e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—ALB—epilepsy syndrome	1.72e-06	4.18e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.7e-06	4.13e-05	CbGpPWpGaD
Guanfacine—ADRA2A—GPCR downstream signaling—AKT1—epilepsy syndrome	1.66e-06	4.04e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.65e-06	4.02e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—CASP3—epilepsy syndrome	1.65e-06	4.01e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—JUN—epilepsy syndrome	1.6e-06	3.89e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—ALB—epilepsy syndrome	1.57e-06	3.81e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—MMP9—epilepsy syndrome	1.56e-06	3.79e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—GPX1—epilepsy syndrome	1.54e-06	3.74e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling by GPCR—AKT1—epilepsy syndrome	1.51e-06	3.67e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—PTGS2—epilepsy syndrome	1.5e-06	3.66e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—SRC—epilepsy syndrome	1.43e-06	3.49e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—VEGFA—epilepsy syndrome	1.4e-06	3.4e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—PTGS2—epilepsy syndrome	1.37e-06	3.34e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—AGT—epilepsy syndrome	1.35e-06	3.28e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—APOE—epilepsy syndrome	1.32e-06	3.21e-05	CbGpPWpGaD
Guanfacine—ADRA2B—Signaling Pathways—AKT1—epilepsy syndrome	1.18e-06	2.86e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—POMC—epilepsy syndrome	1.13e-06	2.76e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Metabolism—AKT1—epilepsy syndrome	1.07e-06	2.59e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—ALB—epilepsy syndrome	1.03e-06	2.51e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	9.04e-07	2.2e-05	CbGpPWpGaD
Guanfacine—ADRA2A—Signaling Pathways—AKT1—epilepsy syndrome	8.92e-07	2.17e-05	CbGpPWpGaD
Guanfacine—CYP2C19—Metabolism—AKT1—epilepsy syndrome	7.55e-07	1.84e-05	CbGpPWpGaD
Guanfacine—CYP2C9—Metabolism—AKT1—epilepsy syndrome	6.89e-07	1.68e-05	CbGpPWpGaD
Guanfacine—CYP3A4—Metabolism—AKT1—epilepsy syndrome	4.54e-07	1.11e-05	CbGpPWpGaD
